About MVision AI
MVision AI is a pioneering healthcare AI company that specializes in developing cloud-based, AI-powered software solutions for radiotherapy treatment planning in cancer care. Their core mission is to enhance the efficiency and impact of cancer treatment by automating repetitive tasks and standardizing radiotherapy planning workflows.
For physicians, MVision AI’s technology, including their flagship products like Contour+ and the Guideline-Based Segmentation (GBS™) suite, offers significant advantages. Contour+ is an AI-powered auto-contouring software that automates the delineation of organs-at-risk and lymph node volumes, adhering to industry contouring guidelines such as ESTRO, EPTN, RTOG, and the UK SABR Consortium. This automation aims to reduce the time spent on treatment planning, allowing clinicians to focus more on personalized treatment plans and ultimately decreasing patient waiting times from weeks to days. The company also offers Verify, a tool for assessing contour accuracy, and Guide, a training environment to improve practitioners’ skills. Their Dose+ product, which received FDA 510(k) clearance in September 2025, provides patient-specific dose predictions to facilitate efficient plan optimization. MVision AI’s solutions are designed to integrate seamlessly into existing clinical workflows, providing valuable insights for faster, more accurate, and streamlined radiotherapy treatment planning. The technology has been utilized in treating over 200,000 cancer patients across 14 countries.
Focus Areas
Business Intelligence
| Technology | Cloud-based AI platform (Workspace+) utilizing 3D deep learning, integrates with DICOM-compliant treatment planning systems |
What Physicians Need to Know
For physicians, MVision AI's solutions aim to significantly reduce the time spent on manual contouring, allowing more focus on individual patient needs and complex cases. The AI-generated contours, trained on international guidelines, promote consistency and reduce inter-planner variability, leading to more standardized and high-quality treatment plans. The modular nature of their Workspace+ platform allows for flexible integration, enabling clinics to adopt specific AI tools based on their priorities without disrupting existing workflows. The transparency in AI outputs, with clinician review and adjustment capabilities, ensures that physicians maintain control and confidence in decision-making. Furthermore, the Dose+ module provides personalized starting points for dose planning, potentially streamlining the optimization process and improving plan consistency.
MVision AI's Workspace+ platform runs as a DICOM service and integrates directly with major DICOM-compliant treatment planning systems such as Varian Eclipse TPS, RayStation, and Monaco. This seamless integration is designed to simplify deployment and complement existing clinical workflows without requiring local tuning or customization. The platform is also GDPR and HIPAA compliant, ensuring data protection and patient privacy.
What the Web Says
MVision AI is a company that provides cloud-based AI software services for radiotherapy treatment planning, aiming to standardize contouring and automate segmentation to streamline workflows. Their Contour+ model has shown high accuracy in clinical evaluations, often requiring only minor or no adjustments in a significant percentage of cases. The software is designed to integrate with existing hospital systems and is HIPAA and GDPR compliant. While there are positive indicators from clinical studies and user experiences, there is limited information available on employer reviews from major platforms like Glassdoor or Capterra specifically for "MVision AI", with some general AI company reviews on Indeed showing mixed sentiment.
Overall: MixedStrengths
- High accuracy in auto-contouring, with studies showing minor or no adjustments needed in many cases.
- Significantly reduces contouring time, allowing clinicians to focus on more complex tasks.
- Standardizes contouring and automates segmentation, enhancing consistency and reliability in treatment planning.
- Integrates seamlessly with existing hospital systems.
- HIPAA and GDPR compliant, ensuring data security and privacy.
- Positive impact on clinical workflows and planning timelines.
Limitations
- Limited public employer reviews specifically for "MVision AI" on major platforms like Glassdoor or Capterra.
- General AI company reviews on platforms like Indeed show mixed sentiment regarding work-life balance, pay, and management.
- AI models reflect training data, and performance may be weaker for atypical anatomies or pediatric cases, requiring human review.
- The actual time and cost savings depend on the extent of human review and editing required for AI-generated contours.
- Requires a lot of data and training to work well, which can be time-consuming and expensive.
- May struggle with unusual conditions or lighting.
Based on reviews from: G2, Glassdoor, Capterra, Software Advice, Indeed, AuntMinnieEurope, Slashdot, alphaXRT, AVIA Marketplace, The Bridgwater Brief, Reddit
Last updated: 2026-10-25
Videos
News, demos, and interviews about MVision AI.
Videos load interactively. If none appear, search YouTube for MVision AI →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded MVision AI.
Related Companies
The Utah Medical Licensing Board is a state governmental agency responsible for regulating the licensing and practice of medical professionals within Utah. It operates under the Utah Division of Professional Licensing (DOPL), which is part of the Department of Commerce. The Board’s primary function is to ensure the health and safety of Utah citizens by […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]
Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]